{"id":830,"date":"2025-05-06T16:34:32","date_gmt":"2025-05-06T14:34:32","guid":{"rendered":"https:\/\/www.dsmtech.it\/bibliografia-age-reader\/"},"modified":"2025-10-14T18:40:20","modified_gmt":"2025-10-14T16:40:20","slug":"bibliography-age-reader","status":"publish","type":"page","link":"https:\/\/www.dsmtech.it\/en\/bibliography-age-reader\/","title":{"rendered":"AGE Reader Bibliography"},"content":{"rendered":"\n<div class=\"wp-block-group alignwide is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"has-desc-2-font-size\"><strong>AGE Reader<\/strong> has been validated in over 300 peer-reviewed publications. The complete bibliography is provided below.<\/p>\n<\/div>\n\n\n\n\n<section id=\"accordion-block_20328a4fb76566ab0dc0fe926dec183a\" class=\"block-accordion alignwide\">\n                    <div class=\"accordion my-4\" id=\"accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 \" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-0\" aria-expanded=\"true\" aria-controls=\"collapse-0\">Pubblicazioni chiave<\/button>\n                <\/h2>\n                <div id=\"collapse-0\" class=\"accordion-collapse collapse show\" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>1.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33435948\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.<\/a>\u00a0Boersma HE, van Waateringe RP, van der Klauw MM, et al. BMC Endocr Disord. 2021;21(1):14. doi:10.1186\/s12902-020-00676-4<\/p>\n<p>2.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30371199\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis<\/a>. Cavero Redondo I, Soriano-Cano A, \u00c1lvarez-Bueno C, et al. J Am Heart Assoc. 2018;7(18):e009833. doi:10.1161\/JAHA.118.009833<\/p>\n<p>3.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25882066\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease.<\/a>\u00a0De Vos LC, Boersema J, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Arterioscler Thromb Vasc Biol. 2015;35(6):1532-1537. doi:10.1161\/ATVBAHA.115.305407<\/p>\n<p>4.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24526694\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.<\/a>\u00a0De Vos LC, Mulder DJ, Smit AJ, et al. Arterioscler Thromb Vasc Biol. 2014;34(4):933-938. doi:10.1161\/ATVBAHA.113.302731<\/p>\n<p>5.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32598375\/\" target=\"_blank\" rel=\"noopener\">It\u2019s all in our skin-Skin autofluorescence-A promising outcome predictor in cardiac surgery: A single centre cohort study.<\/a>\u00a0Hofmann B, Gerull KA, Bloch K, et al. PLoS One. 2020;15(6):e0234847. doi:10.1371\/journal.pone.0234847<\/p>\n<p>6.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19274450\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.<\/a>\u00a0Lutgers HL, Gerrits EG, Graaff R, et al. Diabetologia. 2009;52(5):789-797. doi:10.1007\/s00125-009-1308-9<\/p>\n<p>7.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17192342\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is a strong predictor of cardiac mortality in diabetes.\u00a0<\/a>Meerwaldt R, Lutgers HL, Links TP, et al. Diabetes Care. 2007;30(1):107-112. doi:10.2337\/dc06-1391<\/p>\n<p>8.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32658890\/\" target=\"_blank\" rel=\"noopener\">The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.<\/a>\u00a0Shardlow A, McIntyre NJ, Kolhe NV, et al. PLoS Med. 2020;17(7):e1003163. doi:10.1371\/journal.pmed.1003163<\/p>\n<p>9.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30460578\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.<\/a>\u00a0Van Waateringe RP, Fokkens BT, Slagter SN, et al. Diabetologia. 2019;62(2):269-280. doi:10.1007\/s00125-018-4769-x<\/p>\n<p>10.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32383489\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study.\u00a0<\/a>Viramontes H\u00f6rner D, Selby NM, Taal MW. J Hum Nutr Diet. 2020;33(6):852-861. doi:10.1111\/jhn.12764<\/p>\n<p>11.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24876353\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence associates with vascular calcification in chronic kidney disease.\u00a0<\/a>Wang AYM, Wong CK, Yau YY, Wong S, Chan IHS, Lam CWK. Arterioscler Thromb Vasc Biol. 2014;34(8):1784-1790. doi:10.1161\/ATVBAHA.114.303378<\/p>\n<p>12.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29687658\/\" target=\"_blank\" rel=\"noopener\">Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus.\u00a0<\/a>Yozgatli K, Lefrandt JD, Noordzij MJ, et al. Diabet Med. Published online April 23, 2018. doi:10.1111\/dme.13651<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-1\" aria-expanded=\"true\" aria-controls=\"collapse-1\">AGE Reader in the general population<\/button>\n                <\/h2>\n                <div id=\"collapse-1\" class=\"accordion-collapse collapse \" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>13.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25974028\/\" target=\"_blank\" rel=\"noopener\">A new gender-specific model for skin autofluorescence risk stratification.\u00a0<\/a>Ahmad MS, Damanhouri ZA, Kimhofer T, Mosli HH, Holmes E. Sci Rep. 2015;5:10198. doi:10.1038\/srep10198<\/p>\n<p>14. A<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36346460\/\" target=\"_blank\" rel=\"noopener\">dvanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study.<\/a>\u00a0Arshi B, Chen J, Ikram MA, Zillikens MC, Kavousi M. Diabetologia. Published online November 8, 2022. doi:10.1007\/s00125-022-05821-3<\/p>\n<p>15.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34499644\/\" target=\"_blank\" rel=\"noopener\">Lens fluorescence and skin fluorescence in the Copenhagen Twin Cohort Eye Study: Covariates and heritability.<\/a>\u00a0Bjerager J, Dabbah S, Belmouhand M, Rothenbuehler SP, Sander B, Larsen M. PLOS ONE. 2021;16(9):e0256975. doi:10.1371\/journal.pone.0256975<\/p>\n<p>16.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28249105\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study.<\/a>\u00a0Botros N, Sluik D, van Waateringe RP, de Vries JHM, Geelen A, Feskens EJM. Diabetes Metab Res Rev. 2017;33(5). doi:10.1002\/dmrr.2892<\/p>\n<p>17.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32453418\/\" target=\"_blank\" rel=\"noopener\">The association between dietary and skin advanced glycation end products: the Rotterdam Study.<\/a>\u00a0Chen J, Waqas K, Tan RC, et al. Am J Clin Nutr. 2020;112(1):129-137. doi:10.1093\/ajcn\/nqaa117<\/p>\n<p>18.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37049440\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence Mirrors Surrogate Parameters of Vascular Aging: An Enable Study.<\/a>\u00a0Du T, Brandl B, Hauner H, Skurk T. Nutrients. 2023;15(7):1597. doi:10.3390\/nu15071597<\/p>\n<p>19.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28210490\/\" target=\"_blank\" rel=\"noopener\">Skin advanced glycation end-products evaluation in infants according to the type of feeding and mother\u2019s smoking habits.\u00a0<\/a>Federico G, Gori M, Randazzo E, Vierucci F. SAGE Open Med. 2016;4:2050312116682126. doi:10.1177\/2050312116682126<\/p>\n<p>20.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33437026\/\" target=\"_blank\" rel=\"noopener\">Serum biomarkers, skin autofluorescence and other methods. Which parameter better illustrates the relationship between advanced glycation end products and arterial stiffness in the general population?<\/a>\u00a0Gelzinsk\u00fd J, Mayer O, Seidlerov\u00e1 J, et al. Hypertens Res. 2021;44(5):518-527. doi:10.1038\/s41440-020-00601-1<\/p>\n<p>21.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29322837\/\" target=\"_blank\" rel=\"noopener\">Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.\u00a0<\/a>Isami F, West BJ, Nakajima S, Yamagishi SI. J Int Med Res. 2018;46(3):1043-1051. doi:10.1177\/0300060517736914<\/p>\n<p>22.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32418416\/\" target=\"_blank\" rel=\"noopener\">Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.\u00a0<\/a>Jankowska M, Bobeff K, Baranowska-Jazwiecka A, et al. Pediatr Endocrinol Diabetes Metab. 2020;26(1):1-9. doi:10.5114\/pedm.2020.93251<\/p>\n<p>23.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36064683\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.\u00a0<\/a>Majchrzak C, Cougnard-Gregoire A, Le-Goff M, et al. Nutr Metab Cardiovasc Dis. Published online August 13, 2022:S0939-4753(22)00336-2. doi:10.1016\/j.numecd.2022.08.009<\/p>\n<p>24.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20597834\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and glycemic variability.\u00a0<\/a>Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ. Diabetes Technol Ther. 2010;12(7):581-585. doi:10.1089\/dia.2010.0014<\/p>\n<p>25.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36920139\/\" target=\"_blank\" rel=\"noopener\">The role of Carcinine treatment on glico-lipidic imbalance of patients with altered blood glucose pattern.\u00a0<\/a>Palmieri B, Vadal\u00e0 M.<\/p>\n<p>26.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37592251\/\" target=\"_blank\" rel=\"noopener\">Early vascular aging as an index of cardiovascular risk in healthy adults: confirmatory factor analysis from the EVasCu study.\u00a0<\/a>Saz-Lara A, Cavero-Redondo I, Pascual-Morena C, et al. Cardiovasc Diabetol. 2023;22(1):209. doi:10.1186\/s12933-023-01947-9<\/p>\n<p>27.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37115823\/\" target=\"_blank\" rel=\"noopener\">Associations between birth parameters and skin autofluorescence advanced glycation end and ankle-brachial index in young adulthood: the Malm\u00f6 Offspring Study.\u00a0<\/a>Sharma S, Sperling J, Jujic A, Bennet L, Christensson A, Nilsson PM. J Hypertens. Published online April 26, 2023. doi:10.1097\/HJH.0000000000003449<\/p>\n<p>28.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36172853\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as tool for cardiovascular and diabetes risk prediction.\u00a0<\/a>Smit AJ, van de Zande SC, Mulder DJ. Curr Opin Nephrol Hypertens. 2022;31(6):522-526. doi:10.1097\/MNH.0000000000000835<\/p>\n<p>29.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18473694\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence increases postprandially in human subjects.\u00a0<\/a>Stirban A, Nandrean S, Negrean M, Koschinsky T, Tschoepe D. Diabetes Technol Ther. 2008;10(3):200-205. doi:10.1089\/dia.2007.0275<\/p>\n<p>30.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35637086\/\" target=\"_blank\" rel=\"noopener\">The relationship of skin autofluorescence with diastolic function and HFA-PEFF score in a general population of older people.\u00a0<\/a>Teren M, Schott A, Sedding D, et al. Nutr Metab Cardiovasc Dis. Published online April 29, 2022:S0939-4753(22)00179-X. doi:10.1016\/j.numecd.2022.04.008<\/p>\n<p>31.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32987221\/\" target=\"_blank\" rel=\"noopener\">A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort).\u00a0<\/a>Van de Zande SC, de Vries JK, van den Akker-Scheek I, Zwerver J, Smit AJ. J Sport Health Sci. Published online September 26, 2020:S2095-2546(20)30123-X. doi:10.1016\/j.jshs.2020.09.007<\/p>\n<p>32.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27271340\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study.\u00a0<\/a>Van Dooren FEP, Pouwer F, Schalkwijk CG, et al. Depress Anxiety. 2017;34(1):59-67. doi:10.1002\/da.22527<\/p>\n<p>33.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30460578\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.\u00a0<\/a>Van Waateringe RP, Fokkens BT, Slagter SN, et al. Diabetologia. 2019;62(2):269-280. doi:10.1007\/s00125-018-4769-x<\/p>\n<p>34.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28632785\/\" target=\"_blank\" rel=\"noopener\">The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation.\u00a0<\/a>Van Waateringe RP, Mook-Kanamori MJ, Slagter SN, et al. PLoS One. 2017;12(6):e0179330. doi:10.1371\/journal.pone.0179330<\/p>\n<p>35.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28572855\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.\u00a0<\/a>Van Waateringe RP, Slagter SN, van Beek AP, et al. Diabetol Metab Syndr. 2017;9:42. doi:10.1186\/s13098-017-0241-1<\/p>\n<p>36.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27002914\/\" target=\"_blank\" rel=\"noopener\">Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.\u00a0<\/a>Van Waateringe RP, Slagter SN, van der Klauw MM, et al. Eur J Clin Invest. 2016;46(5):481-490. doi:10.1111\/eci.12627<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-2\" aria-expanded=\"true\" aria-controls=\"collapse-2\">AGE Reader in Diabetes<\/button>\n                <\/h2>\n                <div id=\"collapse-2\" class=\"accordion-collapse collapse \" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>37.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28931094\/\" target=\"_blank\" rel=\"noopener\">Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus.<\/a>\u00a0Ahmad MS, Kimhofer T, Ahmad S, et al. PLoS One. 2017;12(9):e0185175. doi:10.1371\/journal.pone.0185175<\/p>\n<p>38.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37090128\/\" target=\"_blank\" rel=\"noopener\">Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study.\u00a0<\/a>Aoki E, Hirashima T, Kumamoto Y, et al. Diabetol Int. 2023;14(2):145-154. doi:10.1007\/s13340-022-00608-8<\/p>\n<p>39.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27906877\/\" target=\"_blank\" rel=\"noopener\">Association between small fiber neuropathy and higher skin accumulation of advanced glycation end products in patients with type 1 diabetes.\u00a0<\/a>Araszkiewicz A, Gandecka A, Nowicki M, et al. Pol Arch Med Wewn. 2016;126(11):847-853. doi:10.20452\/pamw.3649<\/p>\n<p>40.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21568748\/\" target=\"_blank\" rel=\"noopener\">Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes.\u00a0<\/a>Araszkiewicz A, Naskret D, Niedzwiecki P, Samborski P, Wierusz-Wysocka B, Zozulinska-Ziolkiewicz D. Diabetes Technol Ther. 2011;13(8):837-842. doi:10.1089\/dia.2011.0043<\/p>\n<p>41.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25582078\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients.\u00a0<\/a>Results from Poznan Prospective Study. Araszkiewicz A, Naskret D, Zozulinska-Ziolkiewicz D, et al. Microvasc Res. 2015;98:62-67. doi:10.1016\/j.mvr.2015.01.002<\/p>\n<p>42.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26239695\/\" target=\"_blank\" rel=\"noopener\">In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.\u00a0<\/a>Araszkiewicz A, Soska J, Borucka K, et al. Microvasc Res. 2015;101:143-147. doi:10.1016\/j.mvr.2015.07.008<\/p>\n<p>43.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25467215\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.\u00a0<\/a>Bakker SF, Tushuizen ME, G\u00f6z\u00fctok E, et al. Nutr Metab Cardiovasc Dis. 2015;25(2):230-235. doi:10.1016\/j.numecd.2014.10.009<\/p>\n<p>44.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25467215\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.\u00a0<\/a>Banser A, Naafs JC, Hoorweg-Nijman JJ, van de Garde EM, van der Vorst MM. Pediatr Diabetes. 2016;17(6):426-432. doi:10.1111\/pedi.12311<\/p>\n<p>45.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28063765\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.\u00a0<\/a>Bentata R, Cougnard-Gr\u00e9goire A, Delyfer MN, et al. J Diabetes Complications. 2017;31(3):619-623. doi:10.1016\/j.jdiacomp.2016.10.028<\/p>\n<p>46.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34176469\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.\u00a0<\/a>Birukov A, Cuadrat R, Polemiti E, Eichelmann F, Schulze MB. Cardiovasc Diabetol. 2021;20(1):110. doi:10.1186\/s12933-021-01296-5<\/p>\n<p>47.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29884175\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.\u00a0<\/a>Blanc-Bisson C, Velayoudom-Cephise FL, Cougnard-Gregoire A, et al. Cardiovasc Diabetol. 2018;17(1):82. doi:10.1186\/s12933-018-0718-8<\/p>\n<p>48.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36526712\/\" target=\"_blank\" rel=\"noopener\">A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population.\u00a0<\/a>Boersma HE, van der Klauw MM, Smit AJ, Wolffenbuttel BHR. Sci Rep. 2022;12(1):21794. doi:10.1038\/s41598-022-26313-9<\/p>\n<p>49.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33435948\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.\u00a0<\/a>Boersma HE, van Waateringe RP, van der Klauw MM, et al. BMC Endocr Disord. 2021;21(1):14. doi:10.1186\/s12902-020-00676-4<\/p>\n<p>50.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37647711\/\" target=\"_blank\" rel=\"noopener\">The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: A longitudinal observational study.\u00a0<\/a>Borderie G, Foussard N, Larroumet A, et al. Journal of Diabetes and its Complications. 2023;37(10):108595. doi:10.1016\/j.jdiacomp.2023.108595<\/p>\n<p>51.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21510765\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.\u00a0<\/a>Bos DC, de Ranitz-Greven WL, de Valk HW. Diabetes Technol Ther. 2011;13(7):773-779. doi:10.1089\/dia.2011.0034<\/p>\n<p>52.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30371199\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis.\u00a0<\/a>Cavero-Redondo I, Soriano-Cano A, \u00c1lvarez-Bueno C, et al. J Am Heart Assoc. 2018;7(18):e009833. doi:10.1161\/JAHA.118.009833<\/p>\n<p>53.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20137994\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.\u00a0<\/a>Chabroux S, Canou\u00ef-Poitrine F, Reffet S, et al. Diabetes Metab. 2010;36(2):152-157. doi:10.1016\/j.diabet.2009.11.003<\/p>\n<p>54.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27770590\/\" target=\"_blank\" rel=\"noopener\">Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications.\u00a0<\/a>Cho YH, Craig ME, Januszewski AS, et al. Diabet Med. 2017;34(4):543-550. doi:10.1111\/dme.13280<\/p>\n<p>55.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35711980\/\" target=\"_blank\" rel=\"noopener\">Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus.<\/a>\u00a0Choi LS, Ahmed K, Kim YS, Yim JE. Heliyon. 2022;8(6):e09571. doi:10.1016\/j.heliyon.2022.e09571<\/p>\n<p>56.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29402596\/\" target=\"_blank\" rel=\"noopener\">Gradual increase in advanced glycation end-products from no diabetes to early and regular gestational diabetes: A case-control study.\u00a0<\/a>Cosson E, Gary F, Nguyen MT, et al. Diabetes Metab. 2019;45(6):586-589. doi:10.1016\/j.diabet.2018.01.007<\/p>\n<p>57.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25586910\/\" target=\"_blank\" rel=\"noopener\">Achilles tendons in people with type 2 diabetes show mildly compromised structure: an ultrasound tissue characterisation study.\u00a0<\/a>De Jonge S, Rozenberg R, Vieyra B, et al. Br J Sports Med. 2015;49(15):995-999. doi:10.1136\/bjsports-2014-093696<\/p>\n<p>58.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21875328\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy.\u00a0<\/a>De Ranitz-Greven WL, Bos DC, Poucki WK, et al. Diabetes Technol Ther. 2012;14(1):43-49. doi:10.1089\/dia.2011.0105<\/p>\n<p>59.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23113747\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.<\/a>\u00a0De Ranitz-Greven WL, Kaasenbrood L, Poucki WK, et al. Diabetes Technol Ther. 2012;14(12):1134-1139. doi:10.1089\/dia.2012.0120<\/p>\n<p>60.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3408990\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products measured by skin autofluorescence in a population with central obesity.\u00a0<\/a>Den Engelsen C, van den Donk M, Gorter KJ, Salom\u00e9 PL, Rutten GE. Dermatoendocrinol. 2012;4(1):33-38. doi:10.4161\/derm.17999<\/p>\n<p>61.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27894750\/\" target=\"_blank\" rel=\"noopener\">Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance.<\/a>\u00a0Dimova R, Tankova T, Guergueltcheva V, et al. J Diabetes Complications. 2017;31(3):537-543. doi:10.1016\/j.jdiacomp.2016.11.002<\/p>\n<p>62.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3577512\/\" target=\"_blank\" rel=\"noopener\">Study design of DIACORE (DIAbetes COhoRtE) &#8211; a cohort study of patients with diabetes mellitus type 2.\u00a0<\/a>D\u00f6rh\u00f6fer L, Lammert A, Krane V, et al. BMC Med Genet. 2013;14:25. doi:10.1186\/1471-2350-14-25<\/p>\n<p>63.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31204497\/\" target=\"_blank\" rel=\"noopener\">Within- and Between-Body-Site Agreement of Skin Autofluorescence Measurements in People With and Without Diabetes-Related Foot Disease.\u00a0<\/a>Fernando ME, Crowther RG, Lazzarini PA, et al. J Diabetes Sci Technol. 2019;13(5):836-846. doi:10.1177\/1932296819853555<\/p>\n<p>64.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34186287\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence is an Independent Predictor of Post Stroke Infection in Diabetes.\u00a0<\/a>Filipov A, Fuchshuber H, Kraus J, Ebert AD, Sandikci V, Alonso A. J Stroke Cerebrovasc Dis. 2021;30(9):105949. doi:10.1016\/j.jstrokecerebrovasdis.2021.105949<\/p>\n<p>65.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35329949\/\" target=\"_blank\" rel=\"noopener\">Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus.\u00a0<\/a>Filipov A, Fuchshuber H, Kraus J, Ebert AD, Sandikci V, Alonso A.J Clin Med. 2022;11(6):1625. doi:10.3390\/jcm11061625<\/p>\n<p>66.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29097003\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study.\u00a0<\/a>Fokkens BT, van Waateringe RP, Mulder DJ, Wolffenbuttel BHR, Smit AJ. Diabetes Metab. 2018;44(5):424-430. doi:10.1016\/j.diabet.2017.09.002<\/p>\n<p>67.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28264049\/\" target=\"_blank\" rel=\"noopener\">Vitreous advanced glycation endproducts and \u03b1-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.\u00a0<\/a>Fokkens BT, Mulder DJ, Schalkwijk CG, Scheijen JL, Smit AJ, Los LI. PLoS One. 2017;12(3):e0173379. doi:10.1371\/journal.pone.0173379<\/p>\n<p>68.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27287226\/\" target=\"_blank\" rel=\"noopener\">Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.<\/a>\u00a0Fokkens BT, Smit AJ. Glycoconj J. 2016;33(4):527-535. doi:10.1007\/s10719-016-9683-1<\/p>\n<p>69.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33762312\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts cancer in subjects with type 2 diabetes.\u00a0<\/a>Foussard N, Larroumet A, Rigo M, et al. BMJ Open Diabetes Res Care. 2021;9(1):e001312. doi:10.1136\/bmjdrc-2020-001312<\/p>\n<p>70.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3869449\/\" target=\"_blank\" rel=\"noopener\">Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.\u00a0<\/a>Fukami K, Yamagishi SI, Sakai K, et al. Rejuvenation Res. 2013;16(6):460-466. doi:10.1089\/rej.2013.1459<\/p>\n<p>71.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27115060\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.\u00a0<\/a>Furst JR, Bandeira LC, Fan WW, et al. J Clin Endocrinol Metab. 2016;101(6):2502-2510. doi:10.1210\/jc.2016-1437<\/p>\n<p>72.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23643347\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.\u00a0<\/a>Genevieve M, Vivot A, Gonzalez C, et al. Diabetes Metab. 2013;39(4):349-354. doi:10.1016\/j.diabet.2013.03.003<\/p>\n<p>73.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18039805\/#:~:text=Results%3A%20After%20a%20mean%20follow,in%20those%20who%20developed%20retinopathy.\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.\u00a0<\/a>Gerrits EG, Lutgers HL, Kleefstra N, et al. Diabetes Care. 2008;31(3):517-521. doi:10.2337\/dc07-1755<\/p>\n<p>74.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5098918\/\" target=\"_blank\" rel=\"noopener\">Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.\u00a0<\/a>Hangai M, Takebe N, Honma H, et al. J Atheroscler Thromb. 2016;23(10):1178-1187. doi:10.5551\/jat.30155<\/p>\n<p>75.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27209548\/\" target=\"_blank\" rel=\"noopener\">The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.<\/a>\u00a0Hashimoto K, Kunikata H, Yasuda M, et al. J Diabetes Complications. 2016;30(7):1371-1377. doi:10.1016\/j.jdiacomp.2016.04.024<\/p>\n<p>76.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36494687\/\" target=\"_blank\" rel=\"noopener\">Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes.\u00a0<\/a>Helleputte S, Calders P, Rodenbach A, et al. Cardiovasc Diabetol. 2022;21:277. doi:10.1186\/s12933-022-01717-z<\/p>\n<p>77.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24795072\/\" target=\"_blank\" rel=\"noopener\">Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.\u00a0<\/a>Hirano T, Iesato Y, Toriyama Y, Imai A, Chiba D, Murata T. J Diabetes Complications. 2014;28(5):729-734. doi:10.1016\/j.jdiacomp.2014.03.003<\/p>\n<p>78.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3348228\/\" target=\"_blank\" rel=\"noopener\">Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects.\u00a0<\/a>Hu H, Han C mao, Hu X lei, Ye W lan, Huang W juan, Smit AJ. J Zhejiang Univ Sci B. 2012;13(5):372-377. doi:10.1631\/jzus.B1100249<\/p>\n<p>79.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24846076\/\" target=\"_blank\" rel=\"noopener\">AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.\u00a0<\/a>Hu H, Jiang H, Ren H, Hu X, Wang X, Han C. Diabetes Metab Res Rev. 2015;31(2):127-137. doi:10.1002\/dmrr.2560<\/p>\n<p>80.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22211881\/\" target=\"_blank\" rel=\"noopener\">Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.\u00a0<\/a>Januszewski AS, Sachithanandan N, Karschimkus C, et al. Diabet Med. 2012;29(6):726-733. doi:10.1111\/j.1464-5491.2011.03562.x<\/p>\n<p>81.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34384706\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank.\u00a0<\/a>Jin Q, Lau ESH, Luk AOY, et al. J Diabetes Complications. 2021;35(10):108015. doi:10.1016\/j.jdiacomp.2021.108015<\/p>\n<p>82.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34895800\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank.\u00a0<\/a>Nutrition, Metabolism and Cardiovascular Diseases. Jin Q, Lau ES, Luk AO, et al. 2021;0(0). doi:10.1016\/j.numecd.2021.10.007<\/p>\n<p>83.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30500546\/#:~:text=These%20therapeutic%20options%20include%20AGE,as%20dietary%20and%20phytotherapeutic%20approaches.\" target=\"_blank\" rel=\"noopener\">Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review.\u00a0<\/a>Jud P, Sourij H. Diabetes Res Clin Pract. 2019;148:54-63. doi:10.1016\/j.diabres.2018.11.016<\/p>\n<p>84.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35833179\/\" target=\"_blank\" rel=\"noopener\">Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study.\u00a0<\/a>Kaminski M, Kulecki M, Lachowski P, et al. Int J Angiol. 2022;31(2):97-106. doi:10.1055\/s-0041-1735209<\/p>\n<p>85.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23301020\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.\u00a0<\/a>Klenovics KS, Boor P, Somoza V, Celec P, Fogliano V, Sebekov\u00e1 K. PLoS One. 2013;8(1):e53056. doi:10.1371\/journal.pone.0053056<\/p>\n<p>86.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27847146\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.\u00a0<\/a>Kouidrat Y, Zaitouni A, Amad A, et al. J Diabetes Complications. 2017;31(1):108-113. doi:10.1016\/j.jdiacomp.2016.10.026<\/p>\n<p>87.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26173772\/\" target=\"_blank\" rel=\"noopener\">Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report.\u00a0<\/a>Krul-Poel YHM, Agca R, Lips P, van Wijland H, Stam F, Simsek S. Cardiovasc Diabetol. 2015;14:89. doi:10.1186\/s12933-015-0250-z<\/p>\n<p>88.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5463261\/#:~:text=Considering%20the%20glucose%20concentrations%20of,to%20the%20accumulation%20of%20AGEs.\" target=\"_blank\" rel=\"noopener\">The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients.\u00a0<\/a>Li Z, Wang G, Zhu YJ, et al. Biosci Rep. 2017;37(3):BSR20170213. doi:10.1042\/BSR20170213<\/p>\n<p>89.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25694437\/\" target=\"_blank\" rel=\"noopener\">The association between skin autofluorescence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai.\u00a0<\/a>Liu C, Xu L, Gao H, et al. Int J Low Extrem Wounds. 2015;14(1):28-36. doi:10.1177\/1534734614568375<\/p>\n<p>90.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24681829\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.\u00a0<\/a>Llaurad\u00f3 G, Ceperuelo-Mallafr\u00e9 V, Vilardell C, et al. J Endocrinol. 2014;221(3):405-413. doi:10.1530\/JOE-13-0407<\/p>\n<p>91.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19274450\/#:~:text=Conclusions%2Finterpretation%3A%20Skin%20autofluorescence%20provides,risk%20for%20developing%20cardiovascular%20events.\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.\u00a0<\/a>Lutgers HL, Gerrits EG, Graaff R, et al. Diabetologia. 2009;52(5):789-797. doi:10.1007\/s00125-009-1308-9<\/p>\n<p>92.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17130200\/#:~:text=Skin%20autofluorescence%20reflecting%20vascular%20damage,at%20risk%20for%20developing%20complications.\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes.\u00a0<\/a>Lutgers HL, Graaff R, Links TP, et al. Diabetes Care. 2006;29(12):2654-2659. doi:10.2337\/dc05-2173<\/p>\n<p>93.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23063897\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence measurement in the clinical practice of diabetology and nephrology.<\/a>\u00a0M\u00e1csai E. Orv Hetil. 2012;153(42):1651-1657. doi:10.1556\/OH.2012.29453<\/p>\n<p>94.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26256498\/\" target=\"_blank\" rel=\"noopener\">Correlations between skin autofluorescence and conventional glycemic markers in patients with diabetes.<\/a>\u00a0M\u00e1csai E, Rakk E, Mil\u00e9der M, Fulcz \u00c1. Orv Hetil. 2015;156(33):1341-1347. doi:10.1556\/650.2015.30229<\/p>\n<p>95.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23343332\/\" target=\"_blank\" rel=\"noopener\">Verification of skin autofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report.<\/a>\u00a0M\u00e1csai E, Tak\u00e1ts Z, Derzbach L, K\u00f6rner A, V\u00e1s\u00e1rhelyi B. Diabetes Technol Ther. 2013;15(3):269-272. doi:10.1089\/dia.2012.0251<\/p>\n<p>96.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35972256\/\" target=\"_blank\" rel=\"noopener\">The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.\u00a0<\/a>Maran A, Morieri ML, Falaguasta D, Avogaro A, Fadini GP. Diabetes Care. Published online August 15, 2022:dc220980. doi:10.2337\/dc22-0980<\/p>\n<p>97.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37672325\/#:~:text=Diabetic%20retinopathy%20(DR)%20is%20a,and%20early%20diagnosis%20of%20DR.\" target=\"_blank\" rel=\"noopener\">Non-invasive skin autofluorescence as a screening method for diabetic retinopathy.\u00a0<\/a>Diabetes Metab Res Rev. Mart\u00ednez-Garc\u00eda I, Cavero-Redondo I, \u00c1lvarez-Bueno C, Pascual-Morena C, G\u00f3mez-Guijarro MD, Saz-Lara A. Published online September 6, 2023:e3721. doi:10.1002\/dmrr.3721<\/p>\n<p>98.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25981634\/\" target=\"_blank\" rel=\"noopener\">Is skin autofluorescence a marker of metabolic memory in pregnant women with diabetes?\u00a0<\/a>Maury E, Savel J, Grouthier V, et al. Diabet Med. 2015;32(12):1575-1579. doi:10.1111\/dme.12803<\/p>\n<p>99.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16021416\/\" target=\"_blank\" rel=\"noopener\">Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.\u00a0<\/a>Meerwaldt R, Links TP, Graaff R, et al. Diabetologia. 2005;48(8):1637-1644. doi:10.1007\/s00125-005-1828-x<\/p>\n<p>100.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17192342\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is a strong predictor of cardiac mortality in diabetes.\u00a0<\/a>Meerwaldt R, Lutgers HL, Links TP, et al. Diabetes Care. 2007;30(1):107-112. doi:10.2337\/dc06-1391<\/p>\n<p>101.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17707942\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence in type 2 diabetes: beyond blood glucose.\u00a0<\/a>Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E. Diabetes Res Clin Pract. 2008;79(1):56-60. doi:10.1016\/j.diabres.2007.07.007<\/p>\n<p>102.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4560872\/\" target=\"_blank\" rel=\"noopener\">Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.\u00a0<\/a>Monnier VM, Sun W, Gao X, et al. Cardiovasc Diabetol. 2015;14:118. doi:10.1186\/s12933-015-0266-4<\/p>\n<p>103.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25053588\/\" target=\"_blank\" rel=\"noopener\">Type 2 diabetes, skin autofluorescence, and brain atrophy.\u00a0<\/a>Diabetes. Moran C, M\u00fcnch G, Forbes JM, et al. 2015;64(1):279-283. doi:10.2337\/db14-0506<\/p>\n<p>104.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27727515\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes.<\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25053588\/\" target=\"_blank\" rel=\"noopener\">\u00a0<\/a>Mori H, Kuroda A, Araki M, et al. J Diabetes Investig. 2017;8(3):377-382. doi:10.1111\/jdi.12582<\/p>\n<p>105.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21665206\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.\u00a0<\/a>Mulder DJ, de Boer JF, Graaff R, et al. Atherosclerosis. 2011;218(1):102-106. doi:10.1016\/j.atherosclerosis.2011.05.011<\/p>\n<p>106.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22937960\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.\u00a0<\/a>Noordzij MJ, Mulder DJ, Oomen PHN, et al. Diabet Med. 2012;29(12):1556-1561. doi:10.1111\/dme.12005<\/p>\n<p>107.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5383547\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.\u00a0<\/a>Osawa S, Katakami N, Kuroda A, et al. J Atheroscler Thromb. 2017;24(3):312-326. doi:10.5551\/jat.35592<\/p>\n<p>108.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30099985\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.<\/a>\u00a0Osawa S, Katakami N, Sato I, et al. J Diabetes Complications. 2018;32(9):839-844. doi:10.1016\/j.jdiacomp.2018.06.009<\/p>\n<p>109.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35451045\/\" target=\"_blank\" rel=\"noopener\">Correlation between skin advanced glycation end products and cardiac autonomic neuropathy among subjects with type 2 diabetes mellitus.\u00a0<\/a>Papachristou S, Pafili K, Trypsianis G, Papazoglou D, Vadikolias K, Papanas N. Exp Clin Endocrinol Diabetes. Published online April 21, 2022. doi:10.1055\/a-1831-0991<\/p>\n<p>110.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33622304\/#:~:text=Advanced%20glycation%20end%2Dproducts%20(AGEs,of%20diabetic%20neuropathy%20(DN).\" target=\"_blank\" rel=\"noopener\">Skin AGEs and diabetic neuropathy.\u00a0<\/a>Papachristou S, Pafili K, Papanas N. BMC Endocr Disord. 2021;21(1):28. doi:10.1186\/s12902-021-00697-7<\/p>\n<p>111.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8645371\/\" target=\"_blank\" rel=\"noopener\">Skin Advanced Glycation End Products among Subjects with Type 2 Diabetes Mellitus with or without Distal Sensorimotor Polyneuropathy.\u00a0<\/a>Papachristou S, Pafili K, Trypsianis G, Papazoglou D, Vadikolias K, Papanas N. J Diabetes Res. 2021;2021:6045677. doi:10.1155\/2021\/6045677<\/p>\n<p>112.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34032928\/\" target=\"_blank\" rel=\"noopener\">Usefulness of skin advanced glycation end products to predict coronary artery calcium score in patients with type 2 diabetes.\u00a0<\/a>Planas A, Sim\u00f3-Servat O, Ba\u00f1eras J, et al. Acta Diabetol. 2021;58(10):1403-1412. doi:10.1007\/s00592-021-01735-5<\/p>\n<p>113.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35682915\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes.\u00a0<\/a>Planas A, Sim\u00f3-Servat O, Hern\u00e1ndez C, Sim\u00f3 R. Int J Mol Sci. 2022;23(11):6234. doi:10.3390\/ijms23116234<\/p>\n<p>114.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36231246\/\" target=\"_blank\" rel=\"noopener\">The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?\u00a0<\/a>Podolakova K, Barak L, Jancova E, Stanik J, Sebekova K, Podracka L. International Journal of Environmental Research and Public Health. 2022;19(19):11950. doi:10.3390\/ijerph191911950<\/p>\n<p>115.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22314141\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products and diabetic cardiovascular disease.\u00a0<\/a>Prasad A, Bekker P, Tsimikas S. Cardiol Rev. 2012;20(4):177-183. doi:10.1097\/CRD.0b013e318244e57c<\/p>\n<p>116.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27235334\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.\u00a0<\/a>Rajaobelina K, Farges B, Nov S, et al. Diabetes Metab Res Rev. 2017;33(2). doi:10.1002\/dmrr.2832<\/p>\n<p>117.\u00a0<a href=\"http:\/\/autofluorescence%20of%20skin%20advanced%20glycation%20end%20products:%20Marker%20of%20Metabolic%20Memory%20in%20Elderly%20Population.\/\" target=\"_blank\" rel=\"noopener\">Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.\u00a0<\/a>Rajaobelina K, Cougnard-Gregoire A, Delcourt C, Gin H, Barberger-Gateau P, Rigalleau V. J Gerontol A Biol Sci Med Sci. 2015;70(7):841-846. doi:10.1093\/gerona\/glu243<\/p>\n<p>118.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28719154\/\" target=\"_blank\" rel=\"noopener\">Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.<\/a>\u00a0Rajaobelina K, Helmer C, V\u00e9layoudom-C\u00e9phise FL, et al. Diabetes Metab Res Rev. 2017;33(7). doi:10.1002\/dmrr.2917<\/p>\n<p>119.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25468311\/\" target=\"_blank\" rel=\"noopener\">Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.\u00a0<\/a>Rigalleau V, Cougnard-Gregoire A, Nov S, et al. J Diabetes Complications. 2015;29(2):270-274. doi:10.1016\/j.jdiacomp.2014.10.011<\/p>\n<p>120.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35752528\/\" target=\"_blank\" rel=\"noopener\">Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure.\u00a0<\/a>Rigalleau V, Larroumet A, Ducos C, et al. J Diabetes Complications. Published online June 21, 2022:108234. doi:10.1016\/j.jdiacomp.2022.108234<\/p>\n<p>121.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32812941\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a marker of glucose memory in type 2 diabetes.\u00a0<\/a>Rigo M, Lecocq M, Brouzeng C, et al. Metabol Open. 2020;7:100038. doi:10.1016\/j.metop.2020.100038<\/p>\n<p>122.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9192809\/\" target=\"_blank\" rel=\"noopener\">Increased skin autofluorescence of advanced glycation end products (AGEs) in subjects with cardiovascular risk factors.\u00a0<\/a>Sakly R, Wolffenbuttel BHR, Khochtali I, et al. Int J Diabetes Dev Ctries. Published online August 2, 2022. doi:10.1007\/s13410-022-01121-z<\/p>\n<p>123.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34299683\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation End Products: New Clinical and Molecular Perspectives.\u00a0<\/a>Salazar J, Navarro C, Ortega \u00c1, et al. Int J Environ Res Public Health. 2021;18(14):7236. doi:10.3390\/ijerph18147236<\/p>\n<p>124.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21430607\/\" target=\"_blank\" rel=\"noopener\">Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes.\u00a0<\/a>Samborski P, Naskret D, Araszkiewicz A, Niedzwiecki P, Zozulinska-Zi\u00f3lkiewicz D, Wierusz-Wysocka B.Pol Arch Med Wewn. 2011;121(3):67-72.<\/p>\n<p>125.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23671885\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus.\u00a0<\/a>Skrha J, Soupal J, Loni Ekali G, et al. J Diabetes Res. 2013;2013:650694. doi:10.1155\/2013\/650694<\/p>\n<p>126.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35644724\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.\u00a0<\/a>J Diabetes Complications. \u0160krha J, Horov\u00e1 E, \u0160oupal J, et al. Published online April 28, 2022:108206. doi:10.1016\/j.jdiacomp.2022.108206<\/p>\n<p>127.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15544475\/\" target=\"_blank\" rel=\"noopener\">The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation.\u00a0<\/a>Smit AJ, Lutgers HL. Curr Med Chem. 2004;11(20):2767-2784. doi:10.2174\/0929867043364342<\/p>\n<p>128.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23750268\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes.<\/a>\u00a0Smit AJ, Smit JM, Botterblom GJ, Mulder DJ. PLoS One. 2013;8(6):e65592. doi:10.1371\/journal.pone.0065592<\/p>\n<p>129.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24634815\/\" target=\"_blank\" rel=\"noopener\">Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.<\/a>\u00a0Stirban A, Gawlowski T, Roden M. Mol Metab. 2014;3(2):94-108. doi:10.1016\/j.molmet.2013.11.006<\/p>\n<p>130.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29872473\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence &#8211; A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.\u00a0<\/a>Stirban A, Heinemann L. Eur Endocrinol. 2014;10(2):106-110. doi:10.17925\/EE.2014.10.02.106<\/p>\n<p>131.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33182320\/\" target=\"_blank\" rel=\"noopener\">Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence.\u00a0<\/a>Takayanagi Y, Yamanaka M, Fujihara J, et al. Antioxidants (Basel). 2020;9(11):1100. doi:10.3390\/antiox9111100<\/p>\n<p>132.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21916970\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.\u00a0<\/a>Tanaka K, Tani Y, Asai J, et al. Diabet Med. 2012;29(4):492-500. doi:10.1111\/j.1464-5491.2011.03448.x<\/p>\n<p>133.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34669666\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence as a Novel and Noninvasive Technology for Advanced Glycation End Products in Diabetic Foot Ulcers: A Systematic Review and Meta-analysis.\u00a0<\/a>Varikasuvu SR, Varshney S, Sulekar H. Adv Skin Wound Care. 2021;34(11):1-8. doi:10.1097\/01.ASW.0000792932.01773.d5<\/p>\n<p>134.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27585632\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.<\/a>\u00a0V\u00e9layoudom-C\u00e9phise FL, Rajaobelina K, Helmer C, et al. Cardiovasc Diabetol. 2016;15(1):127. doi:10.1186\/s12933-016-0448-8<\/p>\n<p>135.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27787940\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is increased in young people with type 1 diabetes exposed to secondhand smoking.\u00a0<\/a>Vollenbrock CE, Van Waateringe RP, Veeze HJ, Aanstoot HJ, Wolffenbuttel BHR. J Diabetes. 2017;9(3):308-310. doi:10.1111\/1753-0407.12498<\/p>\n<p>136.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23631605\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration.\u00a0<\/a>Vouillarmet J, Maucort-Boulch D, Michon P, Thivolet C. Diabetes Technol Ther. 2013;15(7):601-605. doi:10.1089\/dia.2013.0009<\/p>\n<p>137.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31161820\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence Is Associated with Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study.\u00a0<\/a>Wan L, Qin G, Yan W, Sun T. Genet Test Mol Biomarkers. 2019;23(6):387-392. doi:10.1089\/gtmb.2018.0328<\/p>\n<p>138.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20861128\/\" target=\"_blank\" rel=\"noopener\">Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients.\u00a0<\/a>Willemsen S, Hartog JWL, Hummel YM, et al. Eur J Heart Fail. 2011;13(1):76-82. doi:10.1093\/eurjhf\/hfq168<\/p>\n<p>139.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24871684\/\" target=\"_blank\" rel=\"noopener\">Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes.\u00a0<\/a>Yasuda M, Shimura M, Kunikata H, et al. Curr Eye Res. 2015;40(3):338-345. doi:10.3109\/02713683.2014.918152<\/p>\n<p>140.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29177923\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study.\u00a0<\/a>Yoshioka K. Diabetes Ther. 2018;9(1):75-85. doi:10.1007\/s13300-017-0339-3<\/p>\n<p>141.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29687658\/\" target=\"_blank\" rel=\"noopener\">Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus.\u00a0<\/a>Yozgatli K, Lefrandt JD, Noordzij MJ, et al. Diabet Med. Published online April 23, 2018. doi:10.1111\/dme.13651<\/p>\n<p>142.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35443645\/\" target=\"_blank\" rel=\"noopener\">Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy.\u00a0<\/a>Zhao XW, Yue WX, Zhang SW, Chen Q. BMC Endocr Disord. 2022;22:106. doi:10.1186\/s12902-022-00997-6<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-3\" aria-expanded=\"true\" aria-controls=\"collapse-3\">AGE Reader in kidney diseases<\/button>\n                <\/h2>\n                <div id=\"collapse-3\" class=\"accordion-collapse collapse \" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>143.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22804770\/\" target=\"_blank\" rel=\"noopener\">Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.\u00a0<\/a>Adachi T, Fukami K, Yamagishi SI, et al. Nephrology (Carlton). 2012;17(8):689-694. doi:10.1111\/j.1440-1797.2012.01642.x<\/p>\n<p>144.\u00a0<a href=\"https:\/\/academic.oup.com\/ndt\/article\/37\/Supplement_3\/gfac079.006\/6577884\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence profile in Tunisian hemodialysis patients with and without heart failure.\u00a0<\/a>Aloui S, Ajimi K, Hamouda M, et al. Published online November 22, 2021. doi:10.21203\/rs.3.rs-900707\/v1<\/p>\n<p>145.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19934094\/\" target=\"_blank\" rel=\"noopener\">Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?\u00a0<\/a>Arsov S, Graaff R, Morariu AM, et al. Nephrol Dial Transplant. 2010;25(3):885-891. doi:10.1093\/ndt\/gfp564<\/p>\n<p>146.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23612551\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review.<\/a>\u00a0Arsov S, Graaff R, van Oeveren W, et al. Clin Chem Lab Med. 2014;52(1):11-20. doi:10.1515\/cclm-2012-0832<\/p>\n<p>147.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30067789\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.\u00a0<\/a>Calvi\u00f1o J, Cigarran S, Gonzalez-Tabares L, et al. PLoS One. 2018;13(8):e0201118. doi:10.1371\/journal.pone.0201118<\/p>\n<p>148.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30371199\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis.\u00a0<\/a>Cavero-Redondo I, Soriano-Cano A, \u00c1lvarez-Bueno C, et al. J Am Heart Assoc. 2018;7(18):e009833. doi:10.1161\/JAHA.118.009833<\/p>\n<p>149.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24135496\/\" target=\"_blank\" rel=\"noopener\">Tissue advanced glycation end product deposition after kidney transplantation.\u00a0<\/a>Crowley LE, Johnson CP, McIntyre N, et al. Nephron Clin Pract. 2013;124(1-2):54-59. doi:10.1159\/000355692<\/p>\n<p>150.\u00a0<a href=\"https:\/\/www.nature.com\/articles\/s41598-021-88786-4\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.<\/a>\u00a0Forbes JM, Le Bagge S, Righi S, et al. Sci Rep. 2021;11(1):9422. doi:10.1038\/s41598-021-88786-4<\/p>\n<p>151.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28902232\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.\u00a0<\/a>Fran\u00e7a R de A, Esteves A de BA, Borges C de M, et al. J Bras Nefrol. 2017;39(3):253-260. doi:10.5935\/0101-2800.20170042<\/p>\n<p>152.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24875193\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and all-cause mortality in stage 3 CKD.\u00a0<\/a>Fraser SDS, Roderick PJ, McIntyre NJ, et al. Clin J Am Soc Nephrol. 2014;9(8):1361-1368. doi:10.2215\/CJN.09510913<\/p>\n<p>153.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25545539\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.<\/a>\u00a0Furuya F, Shimura H, Takahashi K, et al. Ther Apher Dial. 2015;19(1):40-44. doi:10.1111\/1744-9987.12204<\/p>\n<p>154.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22811692\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence: a pronounced marker of mortality in hemodialysis patients.\u00a0<\/a>Gerrits EG, Lutgers HL, Smeets GHW, et al. Nephron Extra. 2012;2(1):184-191. doi:10.1159\/000339282<\/p>\n<p>155.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19033250\/\" target=\"_blank\" rel=\"noopener\">AGEs, autofluorescence and renal function.\u00a0<\/a>Gerrits EG, Smit AJ, Bilo HJG. Nephrol Dial Transplant. 2009;24(3):710-713. doi:10.1093\/ndt\/gfn634<\/p>\n<p>156.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24164288\/\" target=\"_blank\" rel=\"noopener\">Skin and plasma autofluorescence during hemodialysis: a pilot study.\u00a0<\/a>Graaff R, Arsov S, Ramsauer B, et al.Artif Organs. 2014;38(6):515-518. doi:10.1111\/aor.12205<\/p>\n<p>157.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16597636\/\" target=\"_blank\" rel=\"noopener\">Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.\u00a0<\/a>Hartog JWL, de Vries APJ, Bakker SJL, et al. Nephrol Dial Transplant. 2006;21(8):2263-2269. doi:10.1093\/ndt\/gfl132<\/p>\n<p>158.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19352130\/\" target=\"_blank\" rel=\"noopener\">Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients.\u00a0<\/a>Hartog JWL, Gross S, Oterdoom LH, et al. Transplantation. 2009;87(7):1069-1077. doi:10.1097\/TP.0b013e31819d3173<\/p>\n<p>159.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18722326\/\" target=\"_blank\" rel=\"noopener\">Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.\u00a0<\/a>Hartog JWL, Hummel YM, Voors AA, et al. J Card Fail. 2008;14(7):596-602. doi:10.1016\/j.cardfail.2008.03.008<\/p>\n<p>160.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15168376\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.\u00a0<\/a>Hartog JWL, Smit AJ, van Son WJ, et al. Am J Kidney Dis. 2004;43(6):966-975. doi:10.1053\/j.ajkd.2004.02.008<\/p>\n<p>161.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32044235\/\" target=\"_blank\" rel=\"noopener\">Impact of Dietetic Intervention on Skin Autofluorescence and Nutritional Status in Persons Receiving Dialysis: A Proof of Principle Study.\u00a0<\/a>Journal of Renal Nutrition. H\u00f6rner DV, Willingham FC, Selby NM, Taal MW. 2020;30(6):540-547. doi:10.1053\/j.jrn.2019.12.006<\/p>\n<p>162.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22857897\/\" target=\"_blank\" rel=\"noopener\">Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.\u00a0<\/a>Jiang J, Chen P, Chen J, et al. Atherosclerosis. 2012;224(1):187-194. doi:10.1016\/j.atherosclerosis.2012.06.022<\/p>\n<p>163.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33596571\/\" target=\"_blank\" rel=\"noopener\">Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.\u00a0<\/a>Jiang J, Zhang Y, Chen J, et al. Am J Nephrol. 2021;52(1):8-16. doi:10.1159\/000512385<\/p>\n<p>164.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24456287\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis.\u00a0<\/a>Kimura H, Tanaka K, Kanno M, et al. Ther Apher Dial. 2014;18(5):461-467. doi:10.1111\/1744-9987.12160<\/p>\n<p>165.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5299740\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence in acute kidney injury.\u00a0<\/a>Lavielle A, Rubin S, Boyer A, et al. Crit Care. 2017;21(1):24. doi:10.1186\/s13054-017-1598-0<\/p>\n<p>166.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33803864\/\" target=\"_blank\" rel=\"noopener\">Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis.<\/a>\u00a0Luketin M, Mizdrak M, Boric-Skaro D, et al. Biomolecules. 2021;11(3):456. doi:10.3390\/biom11030456<\/p>\n<p>167.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22849846\/\" target=\"_blank\" rel=\"noopener\">Factors influencing skin autofluorescence of patients with peritoneal dialysis.\u00a0<\/a>M\u00e1csai E, Benke A, Cseh A, V\u00e1s\u00e1rhelyi B. Acta Physiol Hung. 2012;99(2):216-222. doi:10.1556\/APhysiol.99.2012.2.15<\/p>\n<p>168.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22976887\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease.<\/a>\u00a0Makulska I, Szczepanska M, Drozdz D, Polak-Jonkisz D, Zwolinska D. Pediatr Nephrol. 2013;28(1):121-128. doi:10.1007\/s00467-012-2280-z<\/p>\n<p>169.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4372673\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease.\u00a0<\/a>Makulska I, Szczepanska M, Drozdz D, Polak-Jonkisz D, Zwolinska D. Pediatr Nephrol. 2015;30(5):811-819. doi:10.1007\/s00467-014-2997-y<\/p>\n<p>170.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33123361\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy.\u00a0<\/a>Martens RJH, Broers NJH, Canaud B, et al. Clin Kidney J. 2020;13(5):855-866. doi:10.1093\/ckj\/sfz099<\/p>\n<p>171.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19965551\/\" target=\"_blank\" rel=\"noopener\">Tissue-advanced glycation end product concentration in dialysis patients.\u00a0<\/a>McIntyre NJ, Chesterton LJ, John SG, et al. Clin J Am Soc Nephrol. 2010;5(1):51-55. doi:10.2215\/CJN.05350709<\/p>\n<p>172.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21885790\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.\u00a0<\/a>McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Clin J Am Soc Nephrol. 2011;6(10):2356-2363. doi:10.2215\/CJN.02420311<\/p>\n<p>173.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16280473\/\" target=\"_blank\" rel=\"noopener\">\u00a0Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.\u00a0<\/a>Meerwaldt R, Hartog JWL, Graaff R, et al. J Am Soc Nephrol. 2005;16(12):3687-3693. doi:10.1681\/ASN.2005020144<\/p>\n<p>174.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21054666\/\" target=\"_blank\" rel=\"noopener\">Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients.\u00a0<\/a>Nagano M, Fukami K, Yamagishi SI, et al. Nephrology (Carlton). 2011;16(3):299-303. doi:10.1111\/j.1440-1797.2010.01419.x<\/p>\n<p>175.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26014842\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.\u00a0<\/a>Nongnuch A, Davenport A. Nephrology (Carlton). 2015;20(11):862-867. doi:10.1111\/nep.12519<\/p>\n<p>176.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29611208\/\" target=\"_blank\" rel=\"noopener\">The Effect of On-Line Hemodiafiltration, Vegetarian Diet, and Urine Volume on Advanced Glycosylation End Products Measured by Changes in Skin Auto-Fluorescence.\u00a0<\/a>Nongnuch A, Davenport A. Artif Organs. 2018;42(11):1078-1085. doi:10.1111\/aor.13143<\/p>\n<p>177.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19090900\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products in renal failure: an overview.\u00a0<\/a>Noordzij MJ, Lefrandt JD, Smit AJ. J Ren Care. 2008;34(4):207-212. doi:10.1111\/j.1755-6686.2008.00038.x<\/p>\n<p>178.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22160646\/\" target=\"_blank\" rel=\"noopener\">Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients.\u00a0<\/a>Oleniuc M, Schiller A, Secara I, et al. Int Urol Nephrol. 2012;44(5):1441-1449. doi:10.1007\/s11255-011-0097-5<\/p>\n<p>179.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28056864\/\" target=\"_blank\" rel=\"noopener\">Skin- and Plasma autofluorescence in hemodialysis with glucose-free or glucose-containing dialysate.\u00a0<\/a>Ramsauer B, Engels GE, Graaff R, Sikole A, Arsov S, Stegmayr B. BMC Nephrol. 2017;18(1):5. doi:10.1186\/s12882-016-0418-0<\/p>\n<p>180.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22200432\/\" target=\"_blank\" rel=\"noopener\">Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency.\u00a0<\/a>Sebekov\u00e1 K, Klenovicsov\u00e1 K, Ferenczov\u00e1 J, Hedvig J, Podrack\u00e1 L, Heidland A. J Ren Nutr. 2012;22(1):143-148. doi:10.1053\/j.jrn.2011.10.022<\/p>\n<p>181.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32658890\/\" target=\"_blank\" rel=\"noopener\">The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.\u00a0<\/a>Shardlow A, McIntyre NJ, Kolhe NV, et al. PLoS Med. 2020;17(7):e1003163. doi:10.1371\/journal.pmed.1003163<\/p>\n<p>182.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25425437\/\" target=\"_blank\" rel=\"noopener\">Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis.\u00a0<\/a>Siriopol D, Hogas S, Veisa G, et al. Int Urol Nephrol. 2015;47(3):563-569. doi:10.1007\/s11255-014-0870-3<\/p>\n<p>183.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20844429\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.\u00a0<\/a>Smit AJ, Gerrits EG. Curr Opin Nephrol Hypertens. 2010;19(6):527-533. doi:10.1097\/MNH.0b013e32833e9259<\/p>\n<p>184.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25226275\/\" target=\"_blank\" rel=\"noopener\">Progress in risk prediction for people with chronic kidney disease.\u00a0<\/a>Taal MW. Curr Opin Nephrol Hypertens. 2014;23(6):519-524. doi:10.1097\/MNH.0000000000000072<\/p>\n<p>185.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3861518\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study.\u00a0<\/a>Tanaka K, Nakayama M, Kanno M, et al. PLoS One. 2013;8(12):e83799. doi:10.1371\/journal.pone.0083799<\/p>\n<p>186.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20591816\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients.\u00a0<\/a>Tanaka K, Tani Y, Asai J, et al. Nephrol Dial Transplant. 2011;26(1):214-220. doi:10.1093\/ndt\/gfq369<\/p>\n<p>187.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26399335\/\" target=\"_blank\" rel=\"noopener\">Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.\u00a0<\/a>Temma J, Matsuhisa M, Horie T, et al. J Med Invest. 2015;62(3-4):126-129. doi:10.2152\/jmi.62.126<\/p>\n<p>188.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20494372\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease.\u00a0<\/a>Ueno H, Koyama H, Fukumoto S, et al. Metabolism. 2011;60(4):453-459. doi:10.1016\/j.metabol.2010.04.001<\/p>\n<p>189.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18803952\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.<\/a>Ueno H, Koyama H, Tanaka S, et al. Metabolism. 2008;57(10):1452-1457. doi:10.1016\/j.metabol.2008.05.016<\/p>\n<p>190.\u00a0<a href=\"https:\/\/academic.oup.com\/ndt\/article\/35\/Supplement_3\/gfaa142.P1078\/5853869?login=false\" target=\"_blank\" rel=\"noopener\">Impact of a medium cut-off dialyzer on skin autofluorescence in haemodialysis patients.\u00a0<\/a>Viramontes Horner D, Kolhe N, Leung J, Fluck R, Selby N, Taal M. Nephrology Dialysis Transplantation. 2020;35(Supplement_3). doi:10.1093\/ndt\/gfaa142.P1078<\/p>\n<p>191.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32405587\/\" target=\"_blank\" rel=\"noopener\">Factors Associated With Change in Skin Autofluorescence, a Measure of Advanced Glycation End Products, in Persons Receiving Dialysis.\u00a0<\/a>Viramontes H\u00f6rner D, Selby NM, Taal MW. Kidney Int Rep. 2020;5(5):654-662. doi:10.1016\/j.ekir.2020.02.003<\/p>\n<p>192.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32383489\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study.\u00a0<\/a>Viramontes H\u00f6rner D, Selby NM, Taal MW. J Hum Nutr Diet. 2020;33(6):852-861. doi:10.1111\/jhn.12764<\/p>\n<p>193.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31589190\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence: an emerging biomarker in persons with kidney disease.\u00a0<\/a>Viramontes H\u00f6rner D, Taal MW. Curr Opin Nephrol Hypertens. 2019;28(6):507-512. doi:10.1097\/MNH.0000000000000549<\/p>\n<p>194.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24876353\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence associates with vascular calcification in chronic kidney disease.\u00a0<\/a>Wang AYM, Wong CK, Yau YY, Wong S, Chan IHS, Lam CWK. Arterioscler Thromb Vasc Biol. 2014;34(8):1784-1790. doi:10.1161\/ATVBAHA.114.303378<\/p>\n<p>195.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31116778\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with rapid renal function decline in subjects at increased risk of coronary artery disease.\u00a0<\/a>Wang CC, Shen MY, Chang KC, Wang GJ, Liu SH, Chang CT. PLoS One. 2019;14(5):e0217203. doi:10.1371\/journal.pone.0217203<\/p>\n<p>196.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26809145\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis.\u00a0<\/a>Wang CC, Wang YC, Wang GJ, et al. PLoS One. 2016;11(1):e0147771. doi:10.1371\/journal.pone.0147771<\/p>\n<p>197.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37443048\/\" target=\"_blank\" rel=\"noopener\">Coronary artery calcification and aortic valve calcification in patients with kidney failure: a sex-disaggregated study.\u00a0<\/a>Ward LJ, Laucyte-Cibulskiene A, Hernandez L, et al. Biol Sex Differ. 2023;14(1):48. doi:10.1186\/s13293-023-00530-x<\/p>\n<p>198.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33508907\/\" target=\"_blank\" rel=\"noopener\">Treatment of Diabetic Kidney Disease: Current and Future.\u00a0<\/a>Yamazaki T, Mimura I, Tanaka T, Nangaku M. Diabetes Metab J. 2021;45(1):11-26. doi:10.4093\/dmj.2020.021<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-4\" aria-expanded=\"true\" aria-controls=\"collapse-4\">AGE Reader in cardiovascular diseases<\/button>\n                <\/h2>\n                <div id=\"collapse-4\" class=\"accordion-collapse collapse \" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>199.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26625521\/\" target=\"_blank\" rel=\"noopener\">The Relationship Between Level of End-Products of Tissue Glycation and Pulse Wave Velocity in Non-diabetic Patients With Cardiovascular Disease.\u00a0<\/a>Ageev FT, Vitsenia MV, Smirnova MD, Mihailov GV. Kardiologiia. 2015;55(6):63-67. doi:10.18565\/cardio.2015.6.63-67<\/p>\n<p>200.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28655550\/\" target=\"_blank\" rel=\"noopener\">Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm.\u00a0<\/a>Boersema J, de Vos LC, Links TP, et al. J Vasc Surg. 2017;66(6):1696-1703.e1. doi:10.1016\/j.jvs.2017.04.037<\/p>\n<p>201.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30371199\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis.\u00a0<\/a>Cavero-Redondo I, Soriano-Cano A, \u00c1lvarez-Bueno C, et al. J Am Heart Assoc. 2018;7(18):e009833. doi:10.1161\/JAHA.118.009833<\/p>\n<p>202.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35260315\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products via skin autofluorescence as a new biomarker for major adverse cardiovascular events: A meta-analysis of prospective studies.\u00a0<\/a>Chen Q, Huang Q, Liu W, Zhou X. Nutr Metab Cardiovasc Dis. 2022;32(5):1083-1092. doi:10.1016\/j.numecd.2022.01.032<\/p>\n<p>203.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28400456\/\" target=\"_blank\" rel=\"noopener\">Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study &#8211; protocol for a multicentre cross-sectional study.\u00a0<\/a>De Vos LC, Boersema J, Hillebrands JL, et al. BMJ Open. 2017;7(4):e012584. doi:10.1136\/bmjopen-2016-012584<\/p>\n<p>204.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25882066\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease.\u00a0<\/a>De Vos LC, Boersema J, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Arterioscler Thromb Vasc Biol. 2015;35(6):1532-1537. doi:10.1161\/ATVBAHA.115.305407<\/p>\n<p>205.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24526694\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.\u00a0<\/a>De Vos LC, Mulder DJ, Smit AJ, et al. Arterioscler Thromb Vasc Biol. 2014;34(4):933-938. doi:10.1161\/ATVBAHA.113.302731<\/p>\n<p>206.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23139292\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripher al artery disease.\u00a0<\/a>De Vos LC, Noordzij MJ, Mulder DJ, et al. Arterioscler Thromb Vasc Biol. 2013;33(1):131-138. doi:10.1161\/ATVBAHA.112.300016<\/p>\n<p>207.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24376641\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis.\u00a0<\/a>Den Dekker MAM, Zwiers M, van den Heuvel ER, et al. PLoS One. 2013;8(12):e83084. doi:10.1371\/journal.pone.0083084<\/p>\n<p>208.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20154337\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.\u00a0<\/a>Hartog JWL, van de Wal RM, Schalkwijk CG, et al. Eur J Heart Fail. 2010;12(4):397-403. doi:10.1093\/eurjhf\/hfq001<\/p>\n<p>209.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17986469\/\" target=\"_blank\" rel=\"noopener\">Clinical and prognostic value of advanced glycation end-products in chronic heart failure.\u00a0<\/a>Hartog JWL, Voors AA, Schalkwijk CG, et al. Eur Heart J. 2007;28(23):2879-2885. doi:10.1093\/eurheartj\/ehm486<\/p>\n<p>210.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21669961\/\" target=\"_blank\" rel=\"noopener\">Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.\u00a0<\/a>Hartog JWL, Willemsen S, van Veldhuisen DJ, et al. Eur J Heart Fail. 2011;13(8):899-908. doi:10.1093\/eurjhf\/hfr067<\/p>\n<p>211.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611858\/\" target=\"_blank\" rel=\"noopener\">Impact of Hemorheology Assessed by the Microchannel Method on Pulsatility Index of the Common Carotid Artery in Patients With Type 2 Diabetes Mellitus.\u00a0<\/a>Hitsumoto T. J Clin Med Res. 2017;9(7):579-585. doi:10.14740\/jocmr3031w<\/p>\n<p>212.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32595810\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence as a Predictor of First Heart Failure Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction.\u00a0<\/a>Hitsumoto T. Cardiol Res. 2020;11(4):247-255. doi:10.14740\/cr1097<\/p>\n<p>213.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25553578\/\" target=\"_blank\" rel=\"noopener\">Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.\u00a0<\/a>Hofmann B, Jacobs K, Navarrete Santos A, Wienke A, Silber RE, Simm A. Diabetes Metab. 2015;41(5):410-415. doi:10.1016\/j.diabet.2014.12.001<\/p>\n<p>214.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22588061\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?<\/a>\u00a0Hofmann B, Adam AC, Jacobs K, et al. Exp Gerontol. 2013;48(1):38-44. doi:10.1016\/j.exger.2012.04.011<\/p>\n<p>215.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26461346\/\" target=\"_blank\" rel=\"noopener\">The skin autofluorescence reflects the posttranslational glycation grade of the matrix protein collagen.\u00a0<\/a>Jacobs K, Navarrete Santos A, Simm A, Silber RE, Hofmann B. Free Radic Biol Med. 2014;75 Suppl 1:S34. doi:10.1016\/j.freeradbiomed.2014.10.772<\/p>\n<p>216.\u00a0<a href=\"https:\/\/research.rug.nl\/en\/publications\/relation-between-food-and-drinking-habits-and-skin-autofluorescen\" target=\"_blank\" rel=\"noopener\">Relation between food and drinking habits, and skin autofluorescence and intima media thickness in subjects at high cardiovascular risk.\u00a0<\/a>Jochemsen BM, Mulder DJ, van Doormaal JJ, et al. Journal of Food and Nutrition Research (Slovak Republic). Published online 2009. Accessed October 4, 2021.<\/p>\n<p>217.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32326893\/\" target=\"_blank\" rel=\"noopener\">Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients.\u00a0<\/a>Kunimoto M, Shimada K, Yokoyama M, et al. BMC Cardiovasc Disord. 2020;20:195. doi:10.1186\/s12872-020-01484-3<\/p>\n<p>218.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34656131\/\" target=\"_blank\" rel=\"noopener\">Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation.\u00a0<\/a>Kunimoto M, Yokoyama M, Shimada K, et al. Cardiovasc Diabetol. 2021;20:208. doi:10.1186\/s12933-021-01398-0<\/p>\n<p>219.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28229055\/\" target=\"_blank\" rel=\"noopener\">A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness.\u00a0<\/a>Liu CY, Huang QF, Cheng YB, et al. Pulse (Basel). 2017;4(4):208-218. doi:10.1159\/000453581<\/p>\n<p>220.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20597962\/\" target=\"_blank\" rel=\"noopener\">Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease.\u00a0<\/a>Lutgers HL, Graaff R, de Vries R, Smit AJ, Dullaart RPF. Eur J Clin Invest. 2010;40(9):812-817. doi:10.1111\/j.1365-2362.2010.02329.x<\/p>\n<p>221.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20597962\/\" target=\"_blank\" rel=\"noopener\">Clinical relevance of advanced glycation endproducts for vascular surgery.\u00a0<\/a>Meerwaldt R, van der Vaart MG, van Dam GM, et al. Eur J Vasc Endovasc Surg. 2008;36(2):125-131. doi:10.1016\/j.ejvs.2008.01.030<\/p>\n<p>222.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19421362\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events.\u00a0<\/a>Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Neth Heart J. 2009;17(4):162-168. doi:10.1007\/BF03086239<\/p>\n<p>223.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2669246\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence is an independent marker for Acute Myocardial Infarction.\u00a0<\/a>Mulder DJ, van Haelst PL, Graaff R. Circulation. 2005;II(112):371.<\/p>\n<p>224.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17499742\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products.\u00a0<\/a>Mulder DJ, van Haelst PL, Gross S, et al. Atherosclerosis. 2008;197(1):217-223. doi:10.1016\/j.atherosclerosis.2007.03.027<\/p>\n<p>225.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17342417\/\" target=\"_blank\" rel=\"noopener\">The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.\u00a0<\/a>Mulder DJ, van Haelst PL, Wobbes MH, et al. Cardiovasc Drugs Ther. 2007;21(2):91-97. doi:10.1007\/s10557-007-6010-x<\/p>\n<p>226.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19811283\/\" target=\"_blank\" rel=\"noopener\">AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.\u00a0<\/a>Nienhuis HLA, Westra J, Smit AJ, Limburg PC, Kallenberg CGM, Bijl M. Autoimmunity. 2009;42(4):302-304. doi:10.1080\/08916930902831746<\/p>\n<p>227.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21336554\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.\u00a0<\/a>Noordzij MJ, Lefrandt JD, Loeffen EAH, et al. Int J Cardiovasc Imaging. 2012;28(2):431-438. doi:10.1007\/s10554-011-9805-6<\/p>\n<p>228.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19367053\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products in patients with cerebral infarction.\u00a0<\/a>Ohnuki Y, Nagano R, Takizawa S, Takagi S, Miyata T. Intern Med. 2009;48(8):587-591. doi:10.2169\/internalmedicine.48.1390<\/p>\n<p>229.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35196628\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a measure of tissue accumulation of advanced glycation end products, is associated with subclinical atherosclerosis in coronary and carotid arteries.\u00a0<\/a>Pan J. Published online 2022.<\/p>\n<p>230.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24665121\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold.\u00a0<\/a>Schmidt AM. Arterioscler Thromb Vasc Biol. 2014;34(4):697-699. doi:10.1161\/ATVBAHA.114.303419<\/p>\n<p>231.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27365407\/\" target=\"_blank\" rel=\"noopener\">Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.\u00a0<\/a>Schutte E, de Vos LC, Lutgers HL, et al. Arterioscler Thromb Vasc Biol. 2016;36(8):1709-1714. doi:10.1161\/ATVBAHA.116.307771<\/p>\n<p>232.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18448821\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation endproducts in chronic heart failure.\u00a0<\/a>Smit AJ, Hartog JWL, Voors AA, van Veldhuisen DJ. Ann N Y Acad Sci. 2008;1126:225-230. doi:10.1196\/annals.1433.038<\/p>\n<p>233.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23612547\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years.\u00a0<\/a>Tiessen AH, Jager W, ter Bogt NCW, et al. Clin Chem Lab Med. 2014;52(1):121-127. doi:10.1515\/cclm-2012-0825<\/p>\n<p>234.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22703717\/\" target=\"_blank\" rel=\"noopener\">Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations.\u00a0<\/a>Watfa G, Soulis G, Tartagni E, et al. Diabetes Metab. 2012;38(5):413-419. doi:10.1016\/j.diabet.2012.04.004<\/p>\n<p>235.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31366777\/\" target=\"_blank\" rel=\"noopener\">Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.\u00a0<\/a>Yamagishi SI. Circ J. 2019;83(9):1822-1828. doi:10.1253\/circj.CJ-19-0618<\/p>\n<p>236.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25814214\/\" target=\"_blank\" rel=\"noopener\">Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.\u00a0<\/a>Yamagishi SI, Fukami K, Matsui T. Int J Cardiol. 2015;185:263-268. doi:10.1016\/j.ijcard.2015.03.167<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-5\" aria-expanded=\"true\" aria-controls=\"collapse-5\">AGE Reader in perioperative medicine<\/button>\n                <\/h2>\n                <div id=\"collapse-5\" class=\"accordion-collapse collapse \" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>237.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36174927\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products and bone &#8211; How do we measure them and how do they correlate with bone mineral density and fractures? A systematic review and evaluation of precision of measures.<\/a>\u00a0Brandt IAG, Jessen MH, Rimestad DE, H\u00f8jgaard MKF, Vestergaard P. Bone. Published online September 26, 2022:116569. doi:10.1016\/j.bone.2022.116569<\/p>\n<p>238.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32598375\/\" target=\"_blank\" rel=\"noopener\">It\u2019s all in our skin-Skin autofluorescence-A promising outcome predictor in cardiac surgery: A single centre cohort study.<\/a>\u00a0Hofmann B, Gerull KA, Bloch K, et al. PLoS One. 2020;15(6):e0234847. doi:10.1371\/journal.pone.0234847<\/p>\n<p>239.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34526025\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a novel predictor of acute kidney injury after liver resection.\u00a0<\/a>Krasnodebski M, Grat K, Morawski M, et al. World J Surg Oncol. 2021;19(1):276. doi:10.1186\/s12957-021-02394-0<\/p>\n<p>240.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36142988\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence Measurement as Initial Assessment of Hepatic Parenchyma Quality in Patients Undergoing Liver Resection.\u00a0<\/a>Krasnodebski M, Morawski M, Borkowski J, et al. SJ Clin Med. 2022;11(18):5341. doi:10.3390\/jcm11185341<\/p>\n<p>241.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30817296\/\" target=\"_blank\" rel=\"noopener\">Post-translational modification-derived products are associated with frailty status in elderly subjects.\u00a0<\/a>Mahmoudi R, Jaisson S, Badr S, et al. Clin Chem Lab Med. 2019;57(8):1153-1161. doi:10.1515\/cclm-2018-1322<\/p>\n<p>242.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29040310\/\" target=\"_blank\" rel=\"noopener\">Accumulation of advanced glycation end products evaluated by skin autofluorescence and incident frailty in older adults from the Bordeaux Three-City cohort.\u00a0<\/a>Pilleron S, Rajaobelina K, Tabue Teguo M, et al. PLoS One. 2017;12(10):e0186087. doi:10.1371\/journal.pone.0186087<\/p>\n<p>243.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21890102\/\" target=\"_blank\" rel=\"noopener\">Increased skin autofluorescence after colorectal operation reflects surgical stress and postoperative outcome.\u00a0<\/a>Pol HWD, Sibma E, Zeebregts CJ, Pierik EGJM, Meerwaldt R. Am J Surg. 2011;202(5):583-589. doi:10.1016\/j.amjsurg.2010.10.019<\/p>\n<p>244.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35887868\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG).<\/a>\u00a0Reichert S, Hofmann B, Kohnert M, et al.J Clin Med. 2022;11(14):4105. doi:10.3390\/jcm11144105<\/p>\n<p>245.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37021973\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products for preoperative frailty screening in older cardiac surgery patients.\u00a0<\/a>Smoor RM, van Dongen EPA, Verwijmeren L, et al. J Am Geriatr Soc. Published online April 6, 2023. doi:10.1111\/jgs.18361<\/p>\n<p>246.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35099530\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a non-invasive biomarker of advanced glycation end-products (AGEs), is associated with frailty: The Rotterdam study.\u00a0<\/a>Waqas K, Chen J, Rivadeneira F, Uitterlinden AG, Voortman T, Zillikens MC. J Gerontol A Biol Sci Med Sci. Published online January 31, 2022:glac025. doi:10.1093\/gerona\/glac025<\/p>\n<hr \/>\n<h2><a id=\"Altre condizioni patologiche\" name=\"Altre condizioni patologiche\"><\/a>AGE Reader in altre condizioni patologiche<\/h2>\n<p>247.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36326402\/\" target=\"_blank\" rel=\"noopener\">Morbid obesity leads to increased skin autofluorescence independent of metabolic syndrome components.\u00a0<\/a>Apaydin T, Yavuz DG. Turk J Med Sci. 2022;52(4):1085-1092. doi:10.55730\/1300-0144.5411<\/p>\n<p>248.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31253386\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as a tool for cardiovascular risk estimation in patients with rheumatoid arthritis.\u00a0<\/a>Bakker-Aling SH, van Woerkom JM, Zomer TP, Buscher HCJL, van Bemmel T. Eur J Intern Med. 2019;66:e7-e8. doi:10.1016\/j.ejim.2019.06.011<\/p>\n<p>249.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16949402\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a marker of advanced glycation end products and oxidative stress, is increased in recently preeclamptic women.\u00a0<\/a>Blaauw J, Smit AJ, van Pampus MG, et al. Am J Obstet Gynecol. 2006;195(3):717-722. doi:10.1016\/j.ajog.2006.06.086<\/p>\n<p>250.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20701478\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly preeclamptic women.\u00a0<\/a>Coffeng SM, Blaauw J, Souwer ETD, et al. Hypertens Pregnancy. 2011;30(2):231-242. doi:10.3109\/10641955.2010.484085<\/p>\n<p>251.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37537205\/\" target=\"_blank\" rel=\"noopener\">Increased dietary intake of ultraprocessed foods and mitochondrial metabolism alterations in pediatric obesity.\u00a0<\/a>Coppola S, Paparo L, Trinchese G, et al. Sci Rep. 2023;13:12609. doi:10.1038\/s41598-023-39566-9<\/p>\n<p>252.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35745150\/\" target=\"_blank\" rel=\"noopener\">The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders.<\/a>\u00a0D\u2019Cunha NM, Sergi D, Lane MM, et al. Nutrients. 2022;14(12):2421. doi:10.3390\/nu14122421<\/p>\n<p>253.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22168993\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.\u00a0<\/a>De Groot L, Hinkema H, Westra J, et al. Arthritis Res Ther. 2011;13(6):R205.<br \/>\ndoi:10.1186\/ar3538<\/p>\n<p>254.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25587178\/\" target=\"_blank\" rel=\"noopener\">Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?\u00a0<\/a>De Groot L, Jager NA, Westra J, et al. Rheumatology (Oxford). 2015;54(7):1257-1261. doi:10.1093\/rheumatology\/keu459<\/p>\n<p>255.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17848401\/\" target=\"_blank\" rel=\"noopener\">Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.<\/a>\u00a0De Leeuw K, Graaff R, de Vries R, et al. Rheumatology (Oxford). 2007;46(10):1551-1556. doi:10.1093\/rheumatology\/kem215<\/p>\n<p>256.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19854707\/\" target=\"_blank\" rel=\"noopener\">Increased accumulation of advanced glycation endproducts in patients with Wegener\u2019s granulomatosis.\u00a0<\/a>De Leeuw K, Nienhuis H, Smit A, Stegeman C, Kallenberg C, Bijl M. Ann Rheum Dis. 2010;69(3):625-627. doi:10.1136\/ard.2009.123851<\/p>\n<p>257.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17570077\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.\u00a0<\/a>Den Hollander NC, Mulder DJ, Graaff R, et al. J Inherit Metab Dis. 2007;30(6):916-923. doi:10.1007\/s10545-007-0507-0<\/p>\n<p>258.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36692158\/\" target=\"_blank\" rel=\"noopener\">Noninvasive Skin Autofluorescence of Advanced Glycation End Products for Detecting Ossification of the Posterior Longitudinal Ligament in the Thoracic Spine.\u00a0<\/a>Doi T, Horii C, Tozawa K, et al. Spine (Phila Pa 1976). 2023;48(4):E40-E45. doi:10.1097\/BRS.0000000000004516<\/p>\n<p>259.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27926755\/\" target=\"_blank\" rel=\"noopener\">Surface Area of Detachment, Proliferative Vitreoretinopathy, and Pulse Pressure, but not AGEs, are Associated With Retinal Redetachment.\u00a0<\/a>Fokkens BT, Mulder DJ, Nugteren MB, et al. Invest Ophthalmol Vis Sci. 2016;57(15):6633-6638. doi:10.1167\/iovs.16-20735<\/p>\n<p>260.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36649922\/\" target=\"_blank\" rel=\"noopener\">Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction.\u00a0<\/a>Fujita N, Ishida M, Iwane T, et al. World J Mens Health. Published online January 3, 2023. doi:10.5534\/wjmh.220154<\/p>\n<p>261.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23645408\/\" target=\"_blank\" rel=\"noopener\">Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.<\/a>\u00a0Gopal P, Reynaert NL, Scheijen JLJM, et al. Eur Respir J. 2014;43(2):430-438. doi:10.1183\/09031936.00135312<\/p>\n<p>262.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20500823\/\" target=\"_blank\" rel=\"noopener\">Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study.\u00a0<\/a>Greven WL, Smit JM, Rommes JH, Spronk PE. BMC Clin Pathol. 2010;10:4. doi:10.1186\/1472-6890-10-4<\/p>\n<p>263.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32574898\/\" target=\"_blank\" rel=\"noopener\">Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study.\u00a0<\/a>Hagen JM, Sutterland AL, Edrisy S, Tan HL, de Haan L. Psychiatry Res. 2020;291:113192. doi:10.1016\/j.psychres.2020.113192<\/p>\n<p>264.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28445633\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk.\u00a0<\/a>Hagen JM, Sutterland AL, Koeter MW, Lutter R, Cohen D, de Haan L. J Clin Psychiatry. 2017;78(9):1395-1401. doi:10.4088\/JCP.16m10972<\/p>\n<p>265.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33601681\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis.\u00a0<\/a>Hagen JM, Sutterland AL, Liefers T, et al. J Affect Disord. 2021;282:1082-1089. doi:10.1016\/j.jad.2020.12.202<\/p>\n<p>266.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28405811\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products as a biomarker for incisional hernia.\u00a0<\/a>Harlaar JJ, Eker HH, Vakalopoulos KA, et al. Hernia. 2017;21(4):537-541. doi:10.1007\/s10029-017-1610-2<\/p>\n<p>267.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31589190\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis.\u00a0<\/a>Hettema ME, Bootsma H, Graaff R, de Vries R, Kallenberg CGM, Smit AJ. Int J Rheumatol. 2011;2011:417813. doi:10.1155\/2011\/417813<\/p>\n<p>268.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23378499\/\" target=\"_blank\" rel=\"noopener\">Local differences in skin autofluorescence may not reflect similar differences in oxidative stress exposure.\u00a0<\/a>Hettema M, Smit AJ. J Rheumatol. 2013;40(2):206. doi:10.3899\/jrheum.121060<\/p>\n<p>269.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27941048\/\" target=\"_blank\" rel=\"noopener\">The association between skin autofluorescence and mean deviation in patients with open-angle glaucoma.\u00a0<\/a>Himori N, Kunikata H, Kawasaki R, et al. Br J Ophthalmol. 2017;101(2):233-238. doi:10.1136\/bjophthalmol-2016-309504<\/p>\n<p>270.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26514963\/\" target=\"_blank\" rel=\"noopener\">The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma.\u00a0<\/a>Himori N, Kunikata H, Shiga Y, et al. Graefes Arch Clin Exp Ophthalmol. 2016;254(2):333-341. doi:10.1007\/s00417-015-3203-z<\/p>\n<p>271.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25034386\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end products in the skin are enhanced in COPD.\u00a0<\/a>Hoonhorst SJM, Lo Tam Loi AT, Hartman JE, et al. Metabolism. 2014;63(9):1149-1156. doi:10.1016\/j.metabol.2014.06.006<\/p>\n<p>272.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27117828\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation endproducts and their receptor in different body compartments in COPD.<\/a>\u00a0Hoonhorst SJM, Lo Tam Loi AT, Pouwels SD, et al. Respir Res. 2016;17:46. doi:10.1186\/s12931-016-0363-2<\/p>\n<p>273.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27858716\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People.\u00a0<\/a>Igase M, Ohara M, Igase K, et al. J Alzheimers Dis. 2017;55(4):1481-1487. doi:10.3233\/JAD-160917<\/p>\n<p>274.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26965223\/\" target=\"_blank\" rel=\"noopener\">Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease.<\/a>\u00a0John M, McKeever TM, Haddad MA, et al. Chron Respir Dis. 2016;13(3):247-255. doi:10.1177\/1479972316636995<\/p>\n<p>275.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27119258\/\" target=\"_blank\" rel=\"noopener\">Relationship between advanced glycation end-product accumulation and low skeletal muscle mass in Japanese men and women.\u00a0<\/a>Kato M, Kubo A, Sugioka Y, et al. Geriatr Gerontol Int. 2017;17(5):785-790. doi:10.1111\/ggi.12787<\/p>\n<p>276.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23615188\/\" target=\"_blank\" rel=\"noopener\">Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia.\u00a0<\/a>Kouidrat Y, Amad A, Desailloud R, et al. J Psychiatr Res. 2013;47(8):1044-1048. doi:10.1016\/j.jpsychires.2013.03.016<\/p>\n<p>277.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30530882\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence in children with and without obesity.\u00a0<\/a>Lentferink YE, van Teeseling L, Knibbe CAJ, van der Vorst MMJ. J Pediatr Endocrinol Metab. 2019;32(1):41-47. doi:10.1515\/jpem-2018-0237<\/p>\n<p>278.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35305050\/\" target=\"_blank\" rel=\"noopener\">Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment.<\/a>\u00a0Maurelli M, Bellinato F, Gisondi P, Girolomoni G.J Eur Acad Dermatol Venereol. 2022;36(8):e629-e631. doi:10.1111\/jdv.18090<\/p>\n<p>279.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36992201\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation End Products and Psoriasis.<\/a>\u00a0Maurelli M, Gisondi P, Girolomoni G. Vaccines (Basel). 2023;11(3):617. doi:10.3390\/vaccines11030617<\/p>\n<p>280.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21145837\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is high in patients with cirrhosis &#8211; further arguing for the implication of Advanced Glycation End products.\u00a0<\/a>Maury E, Vergniol J, Ledinghen V de, Rigalleau V. J Hepatol. 2011;54(5):1079-1080. doi:10.1016\/j.jhep.2010.10.012<\/p>\n<p>281.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27529340\/\" target=\"_blank\" rel=\"noopener\">The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.\u00a0<\/a>Meertens JH, Nienhuis HL, Lefrandt JD, et al. PLoS One. 2016;11(8):e0160893. doi:10.1371\/journal.pone.0160893<\/p>\n<p>282.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21901479\/\" target=\"_blank\" rel=\"noopener\">Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men.\u00a0<\/a>Momma H, Niu K, Kobayashi Y, et al. Osteoporos Int. 2012;23(6):1673-1681. doi:10.1007\/s00198-011-1753-4<\/p>\n<p>283.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21188413\/\" target=\"_blank\" rel=\"noopener\">Skin advanced glycation end product accumulation and muscle strength among adult men.<\/a>\u00a0Momma H, Niu K, Kobayashi Y, et al. Eur J Appl Physiol. 2011;111(7):1545-1552. doi:10.1007\/s00421-010-1779-x<\/p>\n<p>284.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17848401\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.\u00a0<\/a>Nienhuis HL, de Leeuw K, Bijzet J, et al. Rheumatology (Oxford). 2008;47(10):1554-1558. doi:10.1093\/rheumatology\/ken302<\/p>\n<p>285.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29079032\/\" target=\"_blank\" rel=\"noopener\">Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study.\u00a0<\/a>Niihata K, Takahashi S, Kurita N, et al. J Am Med Dir Assoc. 2018;19(3):235-239.e1. doi:10.1016\/j.jamda.2017.09.008<\/p>\n<p>286.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29156622\/\" target=\"_blank\" rel=\"noopener\">Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis.\u00a0<\/a>Papagrigoraki. doi:10.2340\/00015555-2661<\/p>\n<p>287.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22868390\/\" target=\"_blank\" rel=\"noopener\">Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine.\u00a0<\/a>Rombach SM, van den Bogaard B, de Groot E, et al. Hypertension. 2012;60(4):998-1005. doi:10.1161\/HYPERTENSIONAHA.112.195685<\/p>\n<p>288.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28440769\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end-products in morbid obesity and after bariatric surgery: When glycemic memory starts to fail.\u00a0<\/a>S\u00e1nchez E, Baena-Fustegueras JA, de la Fuente MC, et al. Endocrinol Diabetes Nutr. 2017;64(1):4-10. doi:10.1016\/j.endinu.2016.09.009<\/p>\n<p>289.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36615860\/\" target=\"_blank\" rel=\"noopener\">There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project.\u00a0<\/a>S\u00e1nchez E, S\u00e1nchez M, L\u00f3pez-Cano C, et al. Is Nutrients. 2022;15(1):203. doi:10.3390\/nu15010203<\/p>\n<p>290.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29332119\/\" target=\"_blank\" rel=\"noopener\">Autofluorescence of Skin Advanced Glycation End Products as a Risk Factor for Open Angle Glaucoma: The ALIENOR Study.\u00a0<\/a>Schweitzer C, Cougnard-Gregoire A, Rigalleau V, et al. Invest Ophthalmol Vis Sci. 2018;59(1):75-84. doi:10.1167\/iovs.17-22316<\/p>\n<p>291.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25459912\/\" target=\"_blank\" rel=\"noopener\">Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study.\u00a0<\/a>Spauwen PJJ, van Eupen MGA, K\u00f6hler S, et al. J Clin Endocrinol Metab. 2015;100(3):951-960. doi:10.1210\/jc.2014-2754<\/p>\n<p>292.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27763891\/\" target=\"_blank\" rel=\"noopener\">Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.\u00a0<\/a>Sprenger HG, Bierman WF, Martes MI, Graaff R, van der Werf TS, Smit AJ. AIDS. 2017;31(2):241-246. doi:10.1097\/QAD.0000000000001297<\/p>\n<p>293.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34830829\/\" target=\"_blank\" rel=\"noopener\">Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.\u00a0<\/a>Stelwagen J, Meuleman AT, Lubberts S, et al. Cancers (Basel). 2021;13(22):5675. doi:10.3390\/cancers13225675<\/p>\n<p>294.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37326572\/\" target=\"_blank\" rel=\"noopener\">Association of skin autofluorescence and carotid intima-media thickness in acromegaly patients.<\/a>\u00a0Uygur MM, Yasar M, Uygur S\u00d6, Yazici DD, Yavuz DG. Minerva Endocrinol (Torino). Published online June 16, 2023. doi:10.23736\/S2724-6507.23.03951-9<\/p>\n<p>295.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28572855\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.\u00a0<\/a>Van Waateringe RP, Slagter SN, van Beek AP, et al. Diabetol Metab Syndr. 2017;9:42. doi:10.1186\/s13098-017-0241-1<\/p>\n<p>296.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36087928\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a non-invasive biomarker of advanced glycation end products, and its relation to radiographic and MRI based osteoarthritis.\u00a0<\/a>Waqas K, Szilagyi IA, Schiphof D, et al. Osteoarthritis Cartilage. Published online September 7, 2022:S1063-4584(22)00832-9. doi:10.1016\/j.joca.2022.08.014<\/p>\n<p>297.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34453164\/\" target=\"_blank\" rel=\"noopener\">Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.\u00a0<\/a>Waqas K, Zillikens MC. The Journal of Clinical Endocrinology &amp; Metabolism. Published online August 28, 2021. doi:https:\/\/doi.org\/10.1210\/clinem\/dgab632<\/p>\n<p>298.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32323917\/\" target=\"_blank\" rel=\"noopener\">Use of skin advanced glycation end product levels measured using a simple noninvasive method as a biological marker for the diagnosis of neuropsychiatric diseases.\u00a0<\/a>Yamashita H, Fukushima E, Shimomura K, et al. Int J Methods Psychiatr Res. 2020;29(2):e1824. doi:10.1002\/mpr.1824<\/p>\n<p>299.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32523964\/\" target=\"_blank\" rel=\"noopener\">Measures of lung function and their relationship with advanced glycation end-products.<\/a>\u00a0Zaigham S, Persson M, Jujic A, et al. ERJ Open Res. 2020;6(2):00356-02019. doi:10.1183\/23120541.00356-2019<\/p>\n<p>300.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37452881\/\" target=\"_blank\" rel=\"noopener\">Comparison of advanced glycation end products concentration in the skin among patients with rheumatic diseases, with and without comorbid depression: a case\u2013control study.\u00a0<\/a>Zuchowski P, Dura M, Kazmierczak K, Meder G, Waszczak-Jeka M, Jeka D. Rheumatol Int. 2023;43(10):1829-1834. doi:10.1007\/s00296-023-05393-4<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                    <div class=\"accordion-item p-4 rounded-2\">\n                <h2 class=\"accordion-header\">\n                    <button class=\"accordion-button fw-semibold desc-1 p-2 collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#collapse-6\" aria-expanded=\"true\" aria-controls=\"collapse-6\">Technical validation of the AGE Reader<\/button>\n                <\/h2>\n                <div id=\"collapse-6\" class=\"accordion-collapse collapse \" data-bs-parent=\"#accordion-accordion-block_20328a4fb76566ab0dc0fe926dec183a\">\n                    <div class=\"accordion-body p-2 lh-lg\"><p>301.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36012948\/\" target=\"_blank\" rel=\"noopener\">A Prospective Analysis of Skin and Fingertip Advanced Glycation End-Product Devices in Healthy Volunteers.\u00a0<\/a>Adl Amini D, Moser M, Chiapparelli E, et al. J Clin Med. 2022;11(16):4709. doi:10.3390\/jcm11164709<\/p>\n<p>302.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9182719\/\" target=\"_blank\" rel=\"noopener\">N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.\u00a0<\/a>Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. Biochem J. 1997;324 ( Pt 2):565-570. doi:10.1042\/bj3240565<\/p>\n<p>303.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33636313\/\" target=\"_blank\" rel=\"noopener\">The AGE Reader: A non-invasive method to assess long-term tissue damage<\/a>. Atzeni IM, van de Zande SC, Westra J, Zwerver J, Smit AJ, Mulder DJ. Methods. Published online February 23, 2021:S1046-2023(21)00059-1. doi:10.1016\/j.ymeth.2021.02.016<\/p>\n<p>304.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33241137\/\" target=\"_blank\" rel=\"noopener\">Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study.\u00a0<\/a>Atzeni IM, Boersema J, Pas HH, et al. Heliyon. 2020;6(11):e05364. doi:10.1016\/j.heliyon.2020.e05364<\/p>\n<p>305.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28143896\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations.\u00a0<\/a>Da Moura Semedo C, Webb M, Waller H, Khunti K, Davies M. Postgrad Med J. 2017;93(1099):289-294. doi:10.1136\/postgradmedj-2016-134579<\/p>\n<p>306.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8514858\/\" target=\"_blank\" rel=\"noopener\">Accumulation of Maillard reaction products in skin collagen in diabetes and aging.\u00a0<\/a>Dyer DG, Dunn JA, Thorpe SR, et al. J Clin Invest. 1993;91(6):2463-2469. doi:10.1172\/JCI116481<\/p>\n<p>307.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24934506\/\" target=\"_blank\" rel=\"noopener\">GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence.\u00a0<\/a>Eny KM, Lutgers HL, Maynard J, et al. Diabetologia. 2014;57(8):1623-1634. doi:10.1007\/s00125-014-3286-9<\/p>\n<p>308.\u00a0<a href=\"https:\/\/www.spiedigitallibrary.org\/conference-proceedings-of-spie\/5692\/0000\/Instrumentation-for-the-measurement-of-autofluorescence-in-human-skin\/10.1117\/12.588984.short\" target=\"_blank\" rel=\"noopener\">Instrumentation for the measurement of autofluorescence in human skin.\u00a0<\/a>Graaff R, Meerwaldt R, Lutgers HL, et al. 2005;5692:111-118. doi:10.1117\/12.588984<\/p>\n<p>309.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22588061\/\" target=\"_blank\" rel=\"noopener\">Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?<\/a>\u00a0Hofmann B, Adam AC, Jacobs K, et al. Exp Gerontol. 2013;48(1):38-44. doi:10.1016\/j.exger.2012.04.011<\/p>\n<p>310.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29322837\/\" target=\"_blank\" rel=\"noopener\">Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.\u00a0<\/a>Isami F, West BJ, Nakajima S, Yamagishi SI. J Int Med Res. 2018;46(3):1043-1051. doi:10.1177\/0300060517736914<\/p>\n<p>311.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20388050\/\" target=\"_blank\" rel=\"noopener\">Reference values of skin autofluorescence.\u00a0<\/a>Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R. Diabetes Technol Ther. 2010;12(5):399-403. doi:10.1089\/dia.2009.0113<\/p>\n<p>312.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19158862\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence for the risk assessment of chronic complications in diabetes: a broad excitation range is sufficient.\u00a0<\/a>Koetsier M, Lutgers H, Smit AJ, et al. Opt Express. 2009;17(2):509-519. doi:10.1364\/oe.17.000509<\/p>\n<p>313.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20639927\/\" target=\"_blank\" rel=\"noopener\">Skin color independent assessment of aging using skin autofluorescence.\u00a0<\/a>Koetsier M, Nur E, Chunmao H, et al. Opt Express. 2010;18(14):14416-14429. doi:10.1364\/OE.18.014416<\/p>\n<p>314.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23343332\/\" target=\"_blank\" rel=\"noopener\">Verification of skin autofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report.\u00a0<\/a>M\u00e1csai E, Tak\u00e1ts Z, Derzbach L, K\u00f6rner A, V\u00e1s\u00e1rhelyi B. Diabetes Technol Ther. 2013;15(3):269-272. doi:10.1089\/dia.2012.0251<\/p>\n<p>315.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15243705\/\" target=\"_blank\" rel=\"noopener\">Simple non-invasive assessment of advanced glycation endproduct accumulation.\u00a0<\/a>Meerwaldt R, Graaff R, Oomen PHN, et al. Diabetologia. 2004;47(7):1324-1330. doi:10.1007\/s00125-004-1451-2<\/p>\n<p>316.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16037251\/\" target=\"_blank\" rel=\"noopener\">Simple noninvasive measurement of skin autofluorescence.\u00a0<\/a>Meerwaldt R, Links T, Graaff R, et al. Ann N Y Acad Sci. 2005;1043:290-298. doi:10.1196\/annals.1333.036<\/p>\n<p>317.\u00a0<a href=\"https:\/\/www.jstage.jst.go.jp\/article\/gsr\/6\/2\/6_92\/_pdf\/-char\/ja\" target=\"_blank\" rel=\"noopener\">Evaluation of the glycative stress by non-invansive skin AGEs measurement devices.\u00a0<\/a>Morita Y. Accessed October 5, 2021. https:\/\/www.jstage.jst.go.jp\/article\/gsr\/6\/2\/6_92\/_article\/-char\/en<\/p>\n<p>319.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17037967\/\" target=\"_blank\" rel=\"noopener\">Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations.\u00a0<\/a>Mulder DJ, Water TVD, Lutgers HL, et al. Diabetes Technol Ther. 2006;8(5):523-535. doi:10.1089\/dia.2006.8.523<\/p>\n<p>320.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21284484\/\" target=\"_blank\" rel=\"noopener\">Dermal factors influencing measurement of skin autofluorescence.\u00a0<\/a>Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ. Diabetes Technol Ther. 2011;13(2):165-170. doi:10.1089\/dia.2010.0123<\/p>\n<p>321.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24111899\/\" target=\"_blank\" rel=\"noopener\">Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population.\u00a0<\/a>Simon Klenovics K, Koll\u00e1rov\u00e1 R, Hodosy J, Celec P, Sebekov\u00e1 K. Diabet Med. 2014;31(5):581-585. doi:10.1111\/dme.12326<\/p>\n<p>322.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12974556\/\" target=\"_blank\" rel=\"noopener\">Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1).\u00a0<\/a>Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Eur J Epidemiol. 2003;18(8):793-800. doi:10.1023\/a:1025369623365<\/p>\n<p>323.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21204956\/\" target=\"_blank\" rel=\"noopener\">Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.\u00a0<\/a>Yue X, Hu H, Koetsier M, Graaff R, Han C. Diabet Med. 2011;28(7):818-823. doi:10.1111\/j.1464-5491.2010.03217.x<\/p>\n<\/div>\n                <\/div>\n            <\/div>\n                <\/div>\n    <\/section>\n\n","protected":false},"excerpt":{"rendered":"<p>AGE Reader has been validated in over 300 peer-reviewed publications. The complete bibliography is provided below.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-830","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/pages\/830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/comments?post=830"}],"version-history":[{"count":1,"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/pages\/830\/revisions"}],"predecessor-version":[{"id":846,"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/pages\/830\/revisions\/846"}],"wp:attachment":[{"href":"https:\/\/www.dsmtech.it\/en\/wp-json\/wp\/v2\/media?parent=830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}